mci 154 has been researched along with Anesthesia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, Y; Kitada, Y; Narimatsu, A; Satoh, N; Tobe, A | 1 |
Alajoutsijärvi, A; Fraser, M; Ojala, I; Pippuri, A; Sellin, LC; Törnquist, K | 1 |
Kitada, Y; Narimatsu, A; Okushima, H; Satoh, N; Suzuki, R | 1 |
3 other study(ies) available for mci 154 and Anesthesia
Article | Year |
---|---|
Effects of MCI-154, a novel cardiotonic agent, on mean circulatory filling pressure in anesthetized dogs.
Topics: Anesthesia; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dogs; Female; Heart Rate; Male; Nitroglycerin; Pyridazines; Vascular Resistance | 1990 |
Inhibition of cardiac phosphodiesterase III by the novel cardiotonic agent 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Anesthesia; Animals; Blood Pressure; Calcium; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart Rate; In Vitro Techniques; Injections, Intravenous; Male; Myocardium; Phosphodiesterase Inhibitors; Pyridazines; Rats; Rats, Inbred Strains; Swine; Trabecular Meshwork | 1988 |
Cardiovascular pharmacology of 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties.
Topics: Anesthesia; Animals; Cardiotonic Agents; Dogs; Female; Heart Failure; Hemodynamics; Hindlimb; Male; Propranolol; Pyridazines; Regional Blood Flow; Vasodilator Agents; Verapamil | 1987 |